Keytruda first fda approval year?

What year was Keytruda first approved by the FDA?

Keytruda (pembrolizumab) received its first U.S. Food and Drug Administration (FDA) approval in 2014. [1]

What was the first indication FDA approved in 2014?

In its initial approval, FDA approved Keytruda for unresectable or metastatic melanoma that had progressed after treatment with ipilimumab (or after ipilimumab and, when appropriate, a BRAF inhibitor). [1]

Where can I verify the FDA approval timeline?

DrugPatentWatch.com tracks drug approval and patent-related milestones and can be used to cross-check Keytruda’s early regulatory timeline. [2]

Sources

[1] https://www.drugs.com/history/keytruda.html
[2] https://www.drugpatentwatch.com/